Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis from a phase 2b, randomized, controlled trial

被引：0
|
作者：
Guttman-Yassky, Emma [1 ]
Beck, Lisa A. [2 ]
Anderson, Jaclyn K. [3 ]
Hu, Xiaofei [3 ]
Gu, Yihua [3 ]
Teixeira, Henrique D. [3 ]
Silverberg, Jonathan I. [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY 10029 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
8318
引用
收藏
页码：AB294 / AB294
页数：1
相关论文
共 50 条
  • [21] Abrocitinib treatment in patients with moderate to severe atopic dermatitis: Consistency of efficacy responses from randomized, controlled phase 3 and phase 2b clinical trials
    Simpson, Eric L.
    Gooderham, Melinda
    King, Brett
    Taylor, Susan C.
    Rosmarin, David
    Tatulych, Svitlana
    Nduaka, Chudy
    Williams, David
    Zhang, Weidong
    Rojo, Ricardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB62 - AB62
  • [22] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [23] Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study
    Silverberg, Jonathan, I
    Guttman-Yassky, Emma
    Gooderham, Melinda
    Worm, Margitta
    Rippon, Stephanie
    O'Quinn, Sean
    van der Merwe, Rene
    Kragh, Nana
    Kurbasic, Azra
    Wollenberg, Andreas
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (05) : 576 - +
  • [24] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
    Zhao, Dan-Jie
    Li, Xia
    Lin, Hai-Xia
    Zheng, Hong
    Zhou, Di
    Tang, Peng
    PLOS ONE, 2024, 19 (07):
  • [25] Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: A phase 3 randomized trial
    Bissonnette, R.
    Iversen, L.
    Sofen, H.
    Griffiths, C. E. M.
    Foley, P.
    Romiti, R.
    Bachinsky, M.
    Rottinghaus, S. T.
    Tan, H.
    Proulx, J.
    Valdez, H.
    Gupta, P.
    Mallbris, L.
    Wolk, R.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 37 - 37
  • [26] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
    Zhao, Yan
    Zhang, Jianzhong
    Yang, Bin
    Li, Jingyi
    Ding, Yangfeng
    Wu, Liming
    Zhang, Litao
    Wang, Jinyan
    Zhu, Xiaohong
    Zhang, Furen
    Tao, Xiaohua
    Li, Yumei
    Zhang, Chunlei
    Li, Linfeng
    Lu, Jianyun
    Diao, Qingchun
    Lu, Qianjin
    Man, Xiaoyong
    Li, Fuqiu
    Xia, Xiujuan
    Cheng, Hao
    Jia, Yingmin
    Zhao, Guoqing
    Yan, Jinchun
    Chen, Bo
    CHINESE MEDICAL JOURNAL, 2024, 137 (02) : 200 - 208
  • [27] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
    Zhao Yan
    Zhang Jianzhong
    Yang Bin
    Li Jingyi
    Ding Yangfeng
    Wu Liming
    Zhang Litao
    Wang Jinyan
    Zhu Xiaohong
    Zhang Furen
    Tao Xiaohua
    Li Yumei
    Zhang Chunlei
    Li Linfeng
    Lu Jianyun
    Diao Qingchun
    Lu Qianjin
    Man Xiaoyong
    Li Fuqiu
    Xia Xiujuan
    Cheng Hao
    Jia Yingmin
    Zhao Guoqing
    Yan Jinchun
    Chen Bo
    中华医学杂志英文版, 2024, 137 (02)
  • [28] Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2)
    Silverberg, J. I.
    Mustapa, M. N.
    Reid, F.
    Lei, A.
    Smith, R.
    Moate, R.
    Kelly, A.
    Chen, R.
    Gavala, M.
    Jimenez, E.
    Belvisi, M. G.
    Sadiq, M. W.
    Kell, C.
    Pandya, H. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [29] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
    Guttman-Yassky, Emma
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Weidinger, Stephan
    Hong, H. Chih-ho
    Hendrickson, Barbara
    Dilley, Deanne
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Irvine, Alan D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
  • [30] Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis
    Maurer, Marcus
    Cheung, Dorothy S.
    Theess, Wiebke
    Yang, Xiaoying
    Dolton, Michael
    Guttman, Anna
    Choy, David F.
    Dash, Ajit
    Grimbaldeston, Michele A.
    Soong, Weily
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (06) : 1517 - 1524
12345